Detection of Alzheimer's disease amyloid beta 1‐42, p‐tau, and t‐tau assays-Reference-Cited by-同舟云学术

Detection of Alzheimer's disease amyloid beta 1‐42, p‐tau, and t‐tau assays

Published:2021-07-26 Issue: Volume: Page:
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Harten Argonde C.¹²,Wiste Heather J.³,Weigand Stephen D.³,Mielke Michelle M.¹³,Kremers Walter K.³,Eichenlaub Udo⁴,Dyer Roy B.⁵,Algeciras‐Schimnich Alicia⁵,Knopman David S.¹,Jack Clifford R.⁶,Petersen Ronald C.¹³

Affiliation:

1. Department of Neurology Mayo Clinic Rochester Minnesota USA

2. Department of Neurology and Alzheimer Center Amsterdam UMC Amsterdam the Netherlands

3. Department of Health Sciences Research Mayo Clinic Rochester Minnesota USA

4. Roche Diagnostics International Ltd Rotkreuz Switzerland

5. Department of Laboratory Medicine and Pathology Mayo Clinic Rochester Minnesota USA

6. Department of Radiology Mayo Clinic Rochester Minnesota USA

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/alz.12406

Reference32 articles.

1. Current state of Alzheimer’s fluid biomarkers

2. CSF biomarker variability in the Alzheimer's Association quality control program

3. A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's disease

4. Technical performance of a novel, fully automated electrochemiluminescence immunoassay for the quantitation of β‐amyloid (1–42) in human cerebrospinal fluid

5. Elecsys® Total-Tau and Phospho-Tau (181P) CSF assays: Analytical performance of the novel, fully automated immunoassays for quantification of tau proteins in human cerebrospinal fluid

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interval-specific likelihood ratios and probability-based models for interpreting combined CSF biomarkers for Alzheimer’s disease;Clinica Chimica Acta;2025-01

2. Heterogeneity of cerebral atrophic rate in mild cognitive impairment and its interactive association with proteins related to microglia activity on longitudinal cognitive changes;Archives of Gerontology and Geriatrics;2024-12

3. Current progress in aptamer-based sensors for the detection of protein biomarkers in neurodegenerative diseases;Biosensors and Bioelectronics: X;2024-10

4. Cerebrospinal fluid in the differential diagnosis of Alzheimer’s disease: an update of the literature;Expert Review of Neurotherapeutics;2024-09-04

5. Predicting Cognitive Decline in Amyloid-Positive Patients With Mild Cognitive Impairment or Mild Dementia;Neurology;2024-08-13